MyFinsight
Home
Blog
About
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$3K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation related...
Proceeds from issuance of shares...
Increase (decrease) in employees...
Others
Negative Cash Flow Breakdown
Net loss
Decrease in other accounts recei...
Proceeds from short-term loans (...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-3,855
-2,127
-2,434
-2,106
Depreciation
46
37
48
48
Stock-based compensation related to options granted to employees and directors
2,244
133
143
157
Change in operating lease liability
5
2
8
11
Decrease in other accounts receivable and prepaid expenses
127
-109
-224
-188
Increase (decrease) in trade payables
-
-
647
423
Increase in accrued expense
-
-
85
-
Increase in accounts payable
171
250
-
-
Gain on change in fair value of warrants (note 7)
-
-
0
0
Increase in interest expense
57
82
-
-
Increase (decrease) in other accounts payable and accrued expenses
-
-
-
177
Increase (decrease) in employees related liability and accrued expenses
564
194
716
-
Net cash used in operating activities
-895
-1,320
-740
-1,102
Proceeds from issuance of shares in at-the-market (atm) offering (note 8)
-
-
-1
313
Proceeds from issuance of shares for private placement (note 4)
1,023
970
-
-
Proceeds from short-term loans (note 6)
-125
280
781
0
Proceeds from warrants issuance (note 7)
-
-
0
0
Debt-for-equity swap
-
-
0
0
Net cash provided by financing activities
898
1,250
780
313
Increase (decrease) in cash and cash equivalents
3
-70
40
-789
Cash, cash equivalents and restricted cash at the beginning of the period
206
276
236
371
Cash, cash equivalents and restricted cash at end of the period
209
206
276
236
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
shares for private...
$1,023K
Net cash provided by
financing activities
$898K
(-84.48%↓ Y/Y)
Canceled cashflow
$125K
Increase (decrease) in
cash and cash...
$3K
(-99.54%↓ Y/Y)
Canceled cashflow
$895K
Proceeds from short-term
loans (note 6)
-$125K
(37.19%↑ Y/Y)
Stock-based compensation
related to options...
$2,244K
(83.93%↑ Y/Y)
Increase (decrease) in
employees related...
$564K
Increase in accounts
payable
$171K
Increase in interest
expense
$57K
Depreciation
$46K
(-55.34%↓ Y/Y)
Change in operating
lease liability
$5K
(-92.65%↓ Y/Y)
Net cash used in
operating activities
-$895K
(82.56%↑ Y/Y)
Canceled cashflow
$3,087K
Net loss
-$3,855K
(33.15%↑ Y/Y)
Decrease in other
accounts receivable and...
$127K
(-74.34%↓ Y/Y)
Buy us a coffee